| Control | Diabetes |
---|---|---|
(n = 32) | (n = 32) | |
Age (y) | 64.8 ± 12.5 | 70.2 ± 8.2 |
Sex (% women) | 21.9 | 21.9 |
Platelets (nl) | 248.5 ± 89.4 | 223.0 ± 75.4 |
BMI (kg/m2) | 25.5 ± 3.2 | 30.0 ± 5.4 |
Leucocytes (nl) | 6.9 ± 1.8 | 7.5 ± 2.5 |
HbA1c (%) | 5.6 ± 0.3 | 7.2 ± 1.2 |
Fasting blood glucose (mg/dl) | 84 ± 16.0 | 151 ± 33.1 |
CRP (mg/dl) | 0.6 ± 1.5 | 0.8 ± 1.7 |
Cholesterol (mg/dl) | 160 ± 33.5 | 157 ± 39.3 |
Triglycerides (mg/dl) | 150 ± 69.9 | 165 ± 51.2 |
HDL-cholesterol (mg/dl) | 45.8 ± 11.3 | 46.8 ± 18.9 |
LDL-cholesterol (mg/dl) | 95.1 ± 24.1 | 98.2 ± 28.8 |
Concomitant drugs | Â | Â |
   Statin (%) | 96.9 | 100 |
   CCB (%) | 90.1 | 65.6 |
ASA-100Â mg/d (%) | 100 | 100 |
Antidiabetic drugs | Â | Â |
   Metformin (%) | 0 | 59.4 |
   Insulin (%) | 0 | 31.3 |
   Other/none (%) | 0 | 25.0 |
Clopidogrel | Â | Â |
  Loading dose-300 mg (%) | 43.8 | 40.6 |
  Maintenance dose-75 mg/d (%) | 100 | 100 |